Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2023 Jan 24;31(3):911–912. doi: 10.1016/j.ymthe.2023.01.015

Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection

Xin Ye, Richard Holland, Mark Wood, Chris Pasetka, Lorne Palmer, Eleni Samaridou, Kevin McClintock, Viktoriya Borisevich, Thomas W Geisbert, Robert W Cross, James Heyes
PMCID: PMC10014266  PMID: 36696896

Main text

(Molecular Therapy 31, 269–281; January 2023)

In the originally published version of this article, Figure S9 was included with an error. Incorrect images were copied to the fluorescent microscopic images for the 5 ug/mL Cy3-tetra-mannose-siCD45 and 5 ug/mL Cy3-tetra-GalNAc-siCD45 treated samples.

This error has been corrected online with the inclusion of the correct images. The authors sincerely apologize for this error.

graphic file with name figs9c.jpg

Figure S9 (corrected)

graphic file with name figs9o.jpg

Figure S9 (original)


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES